Skip to main content
Top
Published in: Obesity Surgery 4/2009

01-04-2009 | Research Article

Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients

Authors: Sheng-Bin Chen, Yi-Chih Lee, Kong-Han Ser, Jung-Chien Chen, Shu Chung Chen, Hsing-Fang Hsieh, Wei-Jei Lee

Published in: Obesity Surgery | Issue 4/2009

Login to get access

Abstract

Background

Obesity has been widely recognized as a chronic inflammatory condition and associated with elevated inflammatory indicators including C-reactive protein (CRP) and white blood cell count (WBC). Recent studies have shown elevated CRP or WBC is a significant risk factor for cardiac events and stroke but the clinical significance of CRP and WBC has not been clearly studied in morbidly obese patients. This study is aimed at the clinical significance of WBC and CRP in morbidly obese patients and the change after bariatric surgery.

Methods

The study was a prospectively controlled clinical study. From December 1, 2001 to January 31, 2006, of 640 (442 females and 198 males) consecutive morbid obese patients enrolled in a surgically supervised weight loss program with at least 1 year’s follow-up were examined.

Results

Of the patients, 476 (74.4%) had elevated CRP and 100 (15.6%) had elevated WBC at preoperative study. CRP and WBC were significantly related and both increased with increasing body mass index (BMI). CRP is also increased with increasing waist, glucose level, hemoglobin, albumin, Ca, insulin, C-peptide, and metabolic syndrome while WBC is increased with metabolic syndrome but decreased with increasing age. Multivariate analysis confirmed fasting glucose level and hemoglobin are independent predictors of the elevation of CRP while age is the only independent predictor for elevated WBC. Both WBC and CRP levels decreased rapidly after obesity surgery. These improvements resulted in a 69.8% reduction of CRP and 26.4% reduction of WBC 1 year after surgery. Although individuals who underwent laparoscopic gastric bypass lost significantly more weight (36.8 ± 11.7 kg vs. 17.3 ± 10.8 kg; p = 0.000) and achieved a lower BMI (27.8 ± 4.6 vs. 35.0 ± 5.5; p = 0.000) than individuals who underwent laparoscopic gastric banding, there was no difference in the resolution of elevated CRP 1 year after surgery (95.9% vs. 84.5%; p = 0.169) and WBC (99.4% vs. 98.3%; p = 0.323).

Conclusions

Both baseline WBC and CRP are elevated in morbid obese patients but CRP has a better clinical significance. Significant weight reduction 1 year after surgery markedly reduced CRP and WBC with a resolution rate of 93.9% and 98.2% separately. Obesity surgery performed by laparoscopic surgery is recommended for obese patients with elevated CRP or WBC.
Literature
1.
go back to reference Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.CrossRef Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.CrossRef
2.
go back to reference Dietel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people (Editorial). Obes Surg. 2003;13:329–30.CrossRef Dietel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people (Editorial). Obes Surg. 2003;13:329–30.CrossRef
3.
go back to reference Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70–5.CrossRef Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70–5.CrossRef
4.
go back to reference Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.CrossRef Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.CrossRef
5.
go back to reference Fisch IR, Freedman SH. Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA. 1975;234:500–6.CrossRef Fisch IR, Freedman SH. Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA. 1975;234:500–6.CrossRef
6.
go back to reference Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRef Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRef
7.
go back to reference Lemieux I, Pascot A, Prud’homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. J Am Heart Assoc. 2001;21:961–7. Lemieux I, Pascot A, Prud’homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. J Am Heart Assoc. 2001;21:961–7.
8.
go back to reference Yarnell JW, Baker IA, Sweetnam PM, et al. Fibronogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caephilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836–44.CrossRef Yarnell JW, Baker IA, Sweetnam PM, et al. Fibronogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caephilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836–44.CrossRef
9.
go back to reference Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol. 1990;19:881–8.CrossRef Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol. 1990;19:881–8.CrossRef
10.
go back to reference Mendall MA, Strchan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584–90.CrossRef Mendall MA, Strchan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584–90.CrossRef
11.
go back to reference Tchernof A, Nolan, Sites C, et al. Weight loss reduces C-reactive protein levels in obese post-menopausal women. Circulation. 2002;105:564–9.CrossRef Tchernof A, Nolan, Sites C, et al. Weight loss reduces C-reactive protein levels in obese post-menopausal women. Circulation. 2002;105:564–9.CrossRef
12.
go back to reference Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vas Biol. 2001;21:968–70.CrossRef Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vas Biol. 2001;21:968–70.CrossRef
13.
go back to reference Okita K, Nishijima H, Murakami T, et al. Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol. 2004;24:1868–73.CrossRef Okita K, Nishijima H, Murakami T, et al. Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol. 2004;24:1868–73.CrossRef
14.
go back to reference Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of its association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes. 2002;26:659–62.CrossRef Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of its association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes. 2002;26:659–62.CrossRef
15.
go back to reference Zagorski SM, Papa NN, Chung MH. The effect of weight loss after gastric bypass on C-reactive protein levels. Surg Obes Relat Dis. 2005;1:81–5.CrossRef Zagorski SM, Papa NN, Chung MH. The effect of weight loss after gastric bypass on C-reactive protein levels. Surg Obes Relat Dis. 2005;1:81–5.CrossRef
16.
go back to reference Dixon JB, O’Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16:251–7.CrossRef Dixon JB, O’Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16:251–7.CrossRef
17.
go back to reference Lee WJ, Huang MT, Wang W, et al. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.CrossRef Lee WJ, Huang MT, Wang W, et al. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.CrossRef
18.
go back to reference Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182–6.CrossRef Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182–6.CrossRef
19.
go back to reference Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.CrossRef Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.CrossRef
20.
go back to reference Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.CrossRef Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.CrossRef
21.
go back to reference Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med. 2002;52:213–8.CrossRef Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med. 2002;52:213–8.CrossRef
22.
go back to reference Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation. 2002;105:2462–4.CrossRef Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation. 2002;105:2462–4.CrossRef
23.
go back to reference Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–34.CrossRef Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–34.CrossRef
24.
go back to reference Gabay C, Krshner I. Acute-phase proteins and other systemic responses to inflammation. NEJM. 1999;340:448–54.CrossRef Gabay C, Krshner I. Acute-phase proteins and other systemic responses to inflammation. NEJM. 1999;340:448–54.CrossRef
25.
go back to reference Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low-density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–7.CrossRef Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low-density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–7.CrossRef
26.
go back to reference Ridker PM, Cannon CP, Marrow D, et al. C-reactive protein levels and outcomes after stain therapy. N Engl J Med. 2005;352:20–8.CrossRef Ridker PM, Cannon CP, Marrow D, et al. C-reactive protein levels and outcomes after stain therapy. N Engl J Med. 2005;352:20–8.CrossRef
27.
go back to reference Sjostrom L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef Sjostrom L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef
28.
go back to reference O’Brien PE, Dixon JB, Laurie, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144:625–33.CrossRef O’Brien PE, Dixon JB, Laurie, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144:625–33.CrossRef
29.
go back to reference Lee WJ, Chen HH, Wang W, et al. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459–64.PubMed Lee WJ, Chen HH, Wang W, et al. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459–64.PubMed
30.
go back to reference Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139:1088–92.CrossRef Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139:1088–92.CrossRef
31.
go back to reference Deurenberg P, Deurenberg-Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes. 1998;22:1164–71.CrossRef Deurenberg P, Deurenberg-Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes. 1998;22:1164–71.CrossRef
32.
go back to reference Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27:1294–6.CrossRef Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27:1294–6.CrossRef
33.
go back to reference Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.
Metadata
Title
Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients
Authors
Sheng-Bin Chen
Yi-Chih Lee
Kong-Han Ser
Jung-Chien Chen
Shu Chung Chen
Hsing-Fang Hsieh
Wei-Jei Lee
Publication date
01-04-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 4/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9619-3

Other articles of this Issue 4/2009

Obesity Surgery 4/2009 Go to the issue